WallStSmart

HSBC Holdings PLC ADR (HSBC)vsEthos Technologies Inc. Class A Common Stock (LIFE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HSBC Holdings PLC ADR generates 13027% more annual revenue ($63.77B vs $485.82M). HSBC leads profitability with a 35.0% profit margin vs -22.1%. HSBC earns a higher WallStSmart Score of 63/100 (C+).

HSBC

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 7.5Value: 7.0Quality: 4.0
Piotroski: 4/9Altman Z: 0.33

LIFE

Hold

45

out of 100

Grade: D

Growth: 10.0Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.29

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HSBC5 strengths · Avg: 9.2/10
Market CapQuality
$311.14B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
35.0%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
50.7%10/10

Strong operational efficiency at 50.7%

PEG RatioValuation
0.908/10

Growing faster than its price suggests

P/E RatioValuation
15.0x8/10

Attractively priced relative to earnings

LIFE4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
103.5%10/10

Revenue surging 103.5% year-over-year

EPS GrowthGrowth
161.6%10/10

Earnings expanding 161.6% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Areas to Watch

HSBC3 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.3%4/10

3.3% revenue growth

EPS GrowthGrowth
2.6%4/10

2.6% earnings growth

Altman Z-ScoreHealth
0.332/10

Distress zone — elevated risk

LIFE4 concerns · Avg: 2.0/10
Market CapQuality
$1.60B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

Altman Z-ScoreHealth
1.292/10

Distress zone — elevated risk

Profit MarginProfitability
-22.1%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HSBC

The strongest argument for HSBC centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 35.0% and operating margin at 50.7%. PEG of 0.90 suggests the stock is reasonably priced for its growth.

Bull Case : LIFE

The strongest argument for LIFE centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 103.5% demonstrates continued momentum.

Bear Case : HSBC

The primary concerns for HSBC are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : LIFE

The primary concerns for LIFE are Market Cap, Return on Equity, Altman Z-Score.

Key Dynamics to Monitor

HSBC profiles as a value stock while LIFE is a hypergrowth play — different risk/reward profiles.

LIFE is growing revenue faster at 103.5% — sustainability is the question.

Monitor BANKS - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HSBC scores higher overall (63/100 vs 45/100), backed by strong 35.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HSBC Holdings PLC ADR

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

HSBC Holdings plc offers banking and financial products and services globally. The company is headquartered in London, the United Kingdom.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Want to dig deeper into these stocks?